Patents
- Tepe, Jetze J. and Peddibhotla, Satyamaheshwar, US patent 6,878,735 B2: Preparation of imidazolines as NF-κB inhibitors and anti-inflammatory and antimicrobial agents. Licensed to TCH Pharmaceuticals, INC
- Tepe, Jetze J. US patent filed 04/28/2004, No 10/833,871: Preparation of hymenialdisine Derivatives and Use Thereof. Licensed to EMD Biosciences
- Tepe, Jetze J. and Pinnavaia, Thomas, J. US patent filed 06/14/2004, No 60/579,246: Phosphoprotein Characterization by Solid Phase Enrichment with Organofunctional Mesostructures Silicas.
- Tepe, Jetze J. and Peddibhotla, Satyamaheshwar US patent filed 12/03/2003, US 2003232998:Preparation of imidazolines as NF-κB inhibitors and anti-inflammatory and antimicrobial agents. Licensed to TCH Pharmaceuticals, INC
- Tepe, Jetze J.; Peddibhotla, Satyamaheshwar. US patent filed 05/30/2003 WO 2003101969 A1:Preparation of multi-substituted imidazolines as antiinflammatory and antimicrobial agents. Licensed to TCH Pharmaceuticals, INC
For licensing information please contact: Brad Shaw, Office of Intellectual Properties, MSU, Tel: 517/355-2186